Text Size

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Imperial College London.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
The Margaret Hayton HHT Fund
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00230685
First received: September 29, 2005
Last updated: August 12, 2008
Last verified: August 2008
History of Changes
  Purpose

The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes, brain abscesses, pregnancy related complications or pulmonary hypertension. We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications.


Condition
Telangiectasia, Hereditary Hemorrhagic

Study Type: Observational
Official Title: Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Imperial College London:

Estimated Enrollment: 500
Study Start Date: January 2000
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients attending Hammersmith Hospital

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230685

Contacts
Contact: Claire L Shovlin 0208 383 1000 c.shovlin@imperial.ac.uk

Locations
United Kingdom
Respiratory Medicine, Hammersmith Hospital Recruiting
London, United Kingdom, W12 0NN
Contact: Claire L Shovlin         c.shovlin@imperial.ac.uk    
Principal Investigator: Claire L Shovlin            
Sponsors and Collaborators
Imperial College London
The Margaret Hayton HHT Fund
Investigators
Principal Investigator: Claire L Shovlin Imperial College London
  More Information

No publications provided by Imperial College London

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00230685     History of Changes
Other Study ID Numbers: IC/CLS2
Study First Received: September 29, 2005
Last Updated: August 12, 2008
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Imperial College London:
Pulmonary arteriovenous malformations

Additional relevant MeSH terms:
Arteriovenous Malformations
Aneurysm
Hemangioma
Telangiectasia, Hereditary Hemorrhagic
Telangiectasis
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
 Vascular Diseases
Congenital Abnormalities
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms
Hemostatic Disorders
Hemorrhagic Disorders
Hematologic Diseases

ClinicalTrials.gov processed this record on June 18, 2013